Cutia Therapeutics is a research and development-oriented biopharmaceutical company focusing on dermatology, providing consumers and patients with a full range of professional solutions for skin and hair loss diseases. Kedi Group Hong Kong Stock Exchange updated its prospectus today.
This article is reproduced from: https://www.itjuzi.com/pre-ipo?comname=%E7%A7%91%E7%AC%9B%E9%9B%86%E5%9B%A2
This site is only for collection, and the copyright belongs to the original author.